Horizon Therapeutics Plc
US ˙ NASDAQ ˙ US44047T1097
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityHZNP / Horizon Therapeutics Plc
InstitutionUbs Ag
Latest Disclosed Ownership182,733 shares
Latest Disclosed Value $ 2,244,000
Ubs Ag ownership in HZNP / Horizon Therapeutics Plc

On November 12, 2014 - Ubs Ag filed a 13F-HR form disclosing ownership of 182,733 shares of Horizon Therapeutics Plc (US:HZNP) valued at $2,243,961 USD as of September 30, 2014. The entity filed a previous 13F-HR on August 14, 2014 disclosing 194,069 shares of Horizon Therapeutics Plc. This represents a change in shares of -5.84% during the quarter. The current value of the position is $21,251,848 USD.

Ubs Ag has a history of taking positions in derivatives of the underlying security (HZNP) in the form of stock options. The firm currently holds call options representing 3,800 of underlying shares valued at $47,000 USD and put options representing 2,000 of underlying shares valued at $25,000 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

HZNP / Horizon Therapeutics Plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2014-11-12 2014-09-30 13F HORIZON PHARMA SHS G4617B105 182,733 -11,336 -5.84 2,244 -26.91 0.0017
2014-08-14 2014-06-30 13F HORIZON PHARMA COM 44047T109 194,069 173,325 835.54 3,070 877.71 0.0024
2014-05-16 2014-03-31 13F/A-1 HORIZON PHARMA COM 44047T109 20,744 -78,899 -79.18 314 -58.63 0.0003
2014-05-15 2014-03-31 13F HORIZON PHARMA COM 44047T109 20,744 314
2014-05-21 2013-12-31 13F/A-1 HORIZON PHARMA COM 44047T109 99,643 92,092 1,219.60 759 2,936.00 0.0007
2014-02-14 2013-12-31 13F HORIZON PHARMA COM 44047T109 99,643 759
2013-11-13 2013-09-30 13F HORIZON PHARMA COM 44047T109 7,551 -6,694 -46.99 25 -28.57 0.0000
2013-08-14 2013-06-30 13F HORIZON PHARMA COM 44047T109 14,245 14,245 35 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F HORIZON PHARMA SHS Call 3,800 26.67 47 0.00 n/a n/a n/a
2014-08-14 2014-06-30 13F HORIZON PHARMA COM Call 3,000 -90.00 47 -89.65 n/a n/a n/a
2014-05-16 2014-03-31 13F/A HORIZON PHARMA COM Call 30,000 14.07 454 127.00 n/a n/a n/a
2014-05-15 2014-03-31 13F HORIZON PHARMA COM Call 30,000 454 n/a n/a n/a
2014-05-21 2013-12-31 13F/A HORIZON PHARMA COM Call 26,300 228.75 200 640.74 n/a n/a n/a
2014-02-14 2013-12-31 13F HORIZON PHARMA COM Call 26,300 200 n/a n/a n/a
2013-11-13 2013-09-30 13F HORIZON PHARMA COM Call 8,000 60.00 27 125.00 n/a n/a n/a
2013-08-14 2013-06-30 13F HORIZON PHARMA COM Call 5,000 12 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2014-11-12 2014-09-30 13F HORIZON PHARMA SHS Put 2,000 25.00 25 0.00 n/a n/a n/a
2014-08-14 2014-06-30 13F HORIZON PHARMA COM Put 1,600 60.00 25 66.67 n/a n/a n/a
2014-05-16 2014-03-31 13F/A HORIZON PHARMA COM Put 1,000 0.00 15 87.50 n/a n/a n/a
2014-05-15 2014-03-31 13F HORIZON PHARMA COM Put 1,000 15 n/a n/a n/a
2014-05-21 2013-12-31 13F/A HORIZON PHARMA COM Put 1,000 -66.67 8 -20.00 n/a n/a n/a
2014-02-14 2013-12-31 13F HORIZON PHARMA COM Put 1,000 8 n/a n/a n/a
2013-11-13 2013-09-30 13F HORIZON PHARMA COM Put 3,000 -37.50 10 -16.67 n/a n/a n/a
2013-08-14 2013-06-30 13F HORIZON PHARMA COM Put 4,800 12 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.